XML 48 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2018
Accounting Standards Update 2014-09 | Restatement of beginning balances  
Summary of impacts of adoption of recent accounting pronouncements

 

 

 

 

 

 

 

 

 

 

 

 

    

 

Balance at

    

 

 

    

 

Balance at

 

 

 

 

December 31, 2017

 

 

Adjustment

 

 

January 1, 2018

 

Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

Inventories

 

$

337,216

 

$

(7,064)

 

$

330,152

 

Prepaid and other

 

 

109,791

 

 

6,411

 

 

116,202

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

 

461,579

 

 

(5,706)

 

 

455,873

 

Deferred income taxes

 

 

20,995

 

 

1,292

 

 

22,287

 

Deferred and other non-current liabilities

 

 

5,608

 

 

824

 

 

6,432

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

Retained earnings

 

 

1,301,147

 

 

2,937

 

 

1,304,084

 

 

Accounting Standards Update 2014-09 | Cumulative effect of change  
Summary of impacts of adoption of recent accounting pronouncements

 

 

 

 

 

 

 

 

 

 

 

 

    

For the Year Ended December 31, 2018

 

 

    

 

 

 

 

Balances

 

 

 

 

 

    

 

 

 

 

Without

 

 

Effect of

 

 

    

 

As

    

 

Adoption of

    

 

Change

 

 

 

 

Reported

 

 

ASC 606

 

 

Higher/(Lower)

 

Consolidated Statements of Income

 

 

 

 

 

 

 

 

 

 

Net Sales

 

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

1,426,382

 

$

1,424,701

 

$

1,681

 

Pharma

 

 

954,652

 

 

954,497

 

 

155

 

Food + Beverage

 

 

383,727

 

 

385,001

 

 

(1,274)

 

Costs and Expenses

 

 

 

 

 

 

 

 

 

 

Cost of sales (exclusive of depreciation and amortization)

 

 

1,812,961

 

 

1,811,290

 

 

1,671

 

Provision for income taxes

 

 

71,254

 

 

71,541

 

 

(287)

 

Net income

 

 

194,766

 

 

195,588

 

 

(822)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

December 31, 2018

 

 

    

 

 

 

 

Balances

 

 

 

 

 

    

 

 

 

 

Without

 

 

Effect of

 

 

    

 

As

    

 

Adoption of

    

 

Change

 

 

 

 

Reported

 

 

ASC 606

 

 

Higher/(Lower)

 

Consolidated Balance Sheets

 

 

 

 

 

 

 

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

Inventories

 

$

381,110

 

$

391,315

 

$

(10,205)

 

Prepaid and other

 

 

118,245

 

 

108,490

 

 

9,755

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

 

525,199

 

 

529,168

 

 

(3,969)

 

Deferred income taxes

 

 

53,917

 

 

52,912

 

 

1,005

 

Deferred and other non-current liabilities

 

 

23,465

 

 

23,066

 

 

399

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

Retained earnings

 

 

1,371,826

 

 

1,369,711

 

 

2,115

 

 

Accounting Standards Update 2017-07  
Summary of impacts of adoption of recent accounting pronouncements

 

 

 

 

 

 

 

 

 

 

 

 

 

Original

 

 

 

 

Revised

 

 

    

Balance

    

Adjustment

    

Balance

 

Revised Condensed Consolidated Statements of Income

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 2017

 

 

 

 

 

 

 

 

 

 

Cost of sales (exclusive of depreciation and amortization)

 

$

1,604,181

 

$

(1,111)

 

$

1,603,070

 

Selling, research & development and administrative

 

 

388,281

 

 

(857)

 

 

387,424

 

Total Operating Expenses

 

 

2,147,764

 

 

(1,968)

 

 

2,145,796

 

Operating Income

 

 

321,519

 

 

1,968

 

 

323,487

 

Miscellaneous, net

 

 

8,662

 

 

(1,968)

 

 

6,694

 

Total Other (Expense) Income

 

 

(26,694)

 

 

(1,968)

 

 

(28,662)

 

Income before Income Taxes

 

 

294,825

 

 

 —

 

 

294,825

 

Year Ended December 31, 2016

 

 

 

 

 

 

 

 

 

 

Cost of sales (exclusive of depreciation and amortization)

 

$

1,498,070

 

$

(1,896)

 

$

1,496,174

 

Selling, research & development and administrative

 

 

367,562

 

 

(1,293)

 

 

366,269

 

Total Operating Expenses

 

 

2,020,434

 

 

(3,189)

 

 

2,017,245

 

Operating Income

 

 

310,500

 

 

3,189

 

 

313,689

 

Miscellaneous, net

 

 

2,782

 

 

(3,189)

 

 

(407)

 

Total Other (Expense) Income

 

 

(30,003)

 

 

(3,189)

 

 

(33,192)

 

Income before Income Taxes

 

 

280,497

 

 

 —

 

 

280,497